Jira, Confluence, and Bitbucket are Atlassian’s main tools that help teams plan projects, document work, and manage code. The software is offered via cloud subscriptions or on‑premises, and revenue comes from licenses, support, and training. It works by providing an integrated workspace where teams can organize tasks, share documents, and collaborate on code, with workflows that automate steps and connect with other tools. The company differentiates itself through a broad, connected suite that covers project management, collaboration, and development in one place, with options for scalable deployment across many industries and AI features for media management. Its goal is to help organizations operate more efficiently and coordinate teamwork at scale using flexible, customizable software and services.
Company Size
10,001+
Company Stage
IPO
Headquarters
Sydney, Australia
Founded
2002
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health insurance
Vision insurance
Dental insurance
Life insurance
Flexible or health savings accounts
Short-term disability insurance
Long-term disability insurance
Retirement savings plans
Paid time off
Catered lunches, wellness reimbursements, onsite fitness
Atlassian has surged more than 200% from its April low of $57, defying Wall Street's fears that artificial intelligence would devastate software companies. The collaboration software firm posted exceptional results, with fourth-quarter revenue jumping 28% year-over-year to $1.77 billion, beating analyst expectations of $1.66 billion. The company's AI platform, Rovo, embedded into flagship products Jira and Confluence, is driving growth. Annual recurring revenue from Rovo customers is growing at twice the pace of non-Rovo customers. Rovo-powered agents produce 44% more accurate answers whilst consuming 48% fewer tokens. Operating costs rose just 12% despite strong revenue growth, enabling Atlassian to swing to a $139.1 million profit from a year-earlier loss. Adjusted profit soared 83% to $473.1 million. Despite the rally, shares trade at a price-to-sales ratio of 7.1, below the three-year average of 9.8.
Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and productivity software, today announced it has entered into a definitive ag...
Atlassian shares rose 3% in pre-market trading to $185.12 on Monday as software stocks outperformed semiconductor shares. The move came amid broader market concerns about AI development pace, with chip stocks facing selling pressure. The company recently reported fourth-quarter earnings per share of $1.87, beating analyst estimates of $1.50. Revenue reached $1.766 billion, exceeding expectations of approximately $1.66 billion. Several Wall Street firms raised their price targets following the results. Citi increased its target to $225, Bank of America to $210, and BTIG to $230, all maintaining buy ratings. The gains came as major indices traded lower, with the Nasdaq down 1.9% and the S&P 500 declining 0.8%.
Two software stocks are on investors' watchlists whilst one faces headwinds, according to recent analysis. PubMatic, valued at $791 million, is flagged as a sell due to customer churn reflected in its 96% net revenue retention rate and increasingly competitive market conditions requiring higher sales and marketing spend. HubSpot, worth $11.28 billion, shows promise with 20% annual revenue growth over two years and an 83.2% gross margin. The company maintains steady long-term contract flows, trading at 2.8x forward price-to-sales at $224.65 per share. Atlassian, valued at $41.26 billion, also features on the watchlist. The company provides collaboration and knowledge-sharing tools for teams. Investors are advised to exercise caution as AI threatens to commoditise many software products.
Plato Investment Management Ltd bought a new stake in shares of Atlassian Corporation PLC (NASDAQ:TEAM – Free Report) in the 2nd quarter, Holdings Channel reports. The firm bought 16,434 shares of the technology company’s stock, valued at approximately $1,271,000. Several other hedge funds and other institutional investors have also recently modified their holdings of the […]